Khondrion is a pharmaceutical company focusing on the discovery and development of innovative drugs to treat mitochondrial disease. Khondrion lies on extensive knowledge of mitochondrial disease and a proprietary innovative technology platform. Khondrion presents Phase II KHENERGY trial data supporting Phase III development of KH176 in mitochondrial disease. Clinical signs and symptoms of mitochondrial disease.

Vai al contenuto della pagina. Vai al menu di navigazione. Dipartimento di Scienze mediche e chirurgiche - DIMEC. Gli ambiti, le pubblicazioni, i progetti, le attività. Lauree e Lauree magistrali, i dottorati e gli altri corsi. I servizi offerti, i laboratori, i centri e altre strutture. I cataloghi, i fondi, i servizi di prestito e consultazione.

Research in our lab is focused on the comprehension of the genetic basis of cancer growth. In particular, we investigate short- and long-range social interactions between cancer cells and surrounding populations, i. And how these interactions shape cancer evolution. 1 We use the fruitfly. Genetic systems developed for the investigation of specific biological processes;. In the process under analysis.